$30.990
0.000 (0.00%)Zum Schluss
- Hoch
- 30.990
- Eröffnung
- 30.990
- Volumengewichteter Durchschnittskurs
- —
- Volumen
- 0.00
- Marktkap.
- 654.17M
- Tief
- 30.990
- Umsatz
- 0.00
- EV/EBITDA, TTM
- 10.35
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels. The Company has two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to the retail and e-commerce channels. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. It offers and supplies these products to customers primarily in the United States. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 41 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks.
Analystenbewertungen (5)
Truist Securities
$31
2024-08-08
Truist Securities
2024-08-08
Kursziel
$31
Benchmark
$30
2024-05-10
Benchmark
2024-05-10
Kursziel
$30
Jefferies
$28
2024-03-19
Jefferies
2024-03-19
Kursziel
$28
Jefferies
$22
2023-12-19
Jefferies
2023-12-19
Kursziel
$22
Truist Securities
$30
2023-10-02
Truist Securities
2023-10-02
Kursziel
$30
Bewertungskennzahlen
Event-Zeitleiste
News
5.002-11NewsfilterPetIQ Names Camillo Pane as Chief Executive Officer
- 7.010-09Newsfilter
Kuehn Law Encourages FBMS, WSBC, OB, and PETQ Investors to Contact Law Firm
7.010-09GlobenewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PETQ, FBMS, WSBC, OB on Behalf of Shareholders
7.010-04PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AFBI, PETQ, FBMS on Behalf of Shareholders
7.009-17PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PETQ, BTTR, GATO on Behalf of Shareholders
PETQ FAQ – beantwortet von Alphio AI
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels. The Company has two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to the retail and e-commerce channels. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. It offers and supplies these products to customers primarily in the United States. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 41 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).
5 analysts cover PETQ: 4 rate it Buy, 1 Hold and 0 Sell.
Community
Mehr ↗Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.